Fusion
FAB.LFusion Antibodies plc Price (FAB.L)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
55,556,020
(113.5542)%Revenue and Profitability
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 404,997 | 723,046 | 909,294 | 1,481,265 | 1,913,956 | 2,690,744 | 2,181,838 | 3,895,000 | 4,165,000 | 4,799,000 | 2,901,000 | 1,136,000 |
| Net Income | -468,737 | -113,538 | -85,112 | 1,154,092 | 119,954 | -699,941 | -1,264,382 | -697,000 | -2,899,000 | -1,200,000 | -2,596,000 | -2,226,000 |
| FCF USD | 0 | 0 | -193,247 | 310,809 | -127,645 | -367,403 | -2,478,927 | -275,000 | -1,516,000 | -591,000 | -1,869,000 | -1,771,000 |
| OCF USD | 0 | 0 | -182,050 | 346,570 | -37,374 | 77,192 | -1,098,350 | -166,000 | -1,151,000 | -333,000 | -1,755,000 | -1,769,000 |
Financial Health - DEBT
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.12 | -0.06 | -0.31 | -0.02 | 0.00 | -0.02 | -0.01 |
| D/E | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.08 | 0.05 | 0.02 | 0.07 | 0.02 |
| CA/CL | 0.98 | 0.90 | 1.84 | 1.77 | 2.16 | 9.66 | 4.15 | 2.83 | 4.72 | 3.54 | 1.92 | 3.87 |
| TA/TL | 1.20 | 1.05 | 1.84 | 4.54 | 4.79 | 11.38 | 7.03 | 4.92 | 5.38 | 3.99 | 2.20 | 3.86 |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 77,287 | 139,175 | 380,000 | 230,000 | 69,000 | 75,000 | 43,000 |
Management Performance
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | -953.78% | -773.96% | -44.66% | 79.56% | 6.98% | 1.14% | -23.06% | -13.88% | -63.29% | -31.78% | -211.20% | -119.88% |
| ROE | -1,555.82% | 3,085.27% | -50.27% | 79.21% | 7.03% | -10.65% | -23.62% | -14.48% | -61.07% | -32.57% | -231.17% | -124.15% |
| ROA | 0.00% | -36.17% | -22.94% | 61.77% | 5.56% | -9.71% | -20.25% | -11.54% | -49.73% | -24.42% | -125.90% | -91.98% |
| NM % | -115.74% | -15.70% | -9.36% | 77.91% | 6.27% | -26.01% | -57.95% | -17.89% | -69.60% | -25.01% | -89.49% | -195.95% |
| FCF / R% | 0.00% | 0.00% | -21.25% | 20.98% | -6.67% | -13.65% | -113.62% | -7.06% | -36.40% | -12.32% | -64.43% | -155.90% |
| FCF / NI% | 0.00% | 0.00% | 227.05% | 26.93% | -106.41% | 52.49% | 196.06% | 39.45% | 52.29% | 49.25% | 72.00% | 79.56% |
| Operating Margin (OM) | 0.00 | -9.06 | -7.19 | -3.55 | -2.61 | 0.30 | -0.18 | -0.24 | -0.92 | -1.04 | -2.61 | -8.60 |
Per Share
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | -0.02 | -0.01 | 0.00 | 0.05 | 0.01 | -0.04 | -0.06 | -0.03 | -0.11 | -0.05 | -0.10 | -0.04 |
| SPS | 0.02 | 0.03 | 0.04 | 0.07 | 0.09 | 0.17 | 0.10 | 0.18 | 0.16 | 0.18 | 0.11 | 0.02 |
| OCPS | 0.00 | 0.00 | -0.01 | 0.02 | 0.00 | 0.00 | -0.05 | -0.01 | -0.05 | -0.01 | -0.07 | -0.03 |
| FCPS | 0.00 | 0.00 | -0.01 | 0.01 | -0.01 | -0.02 | -0.11 | -0.01 | -0.06 | -0.02 | -0.07 | -0.03 |
| BVPS | 0.00 | 0.00 | 0.01 | 0.07 | 0.08 | 0.41 | 0.24 | 0.22 | 0.19 | 0.14 | 0.04 | 0.03 |
Per Share - CAGR
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | -0.02 | -0.01 | 0.00 | 0.05 | 0.01 | -0.04 | -0.06 | -0.03 | -0.11 | -0.05 | -0.10 | -0.04 |
| CAGR-SPS | 0.02 | 0.03 | 0.04 | 0.07 | 0.09 | 0.17 | 0.10 | 0.18 | 0.16 | 0.18 | 0.11 | 0.02 |
| CAGR-OCPS | 0.00 | 0.00 | -0.01 | 0.02 | 0.00 | 0.00 | -0.05 | -0.01 | -0.05 | -0.01 | -0.07 | -0.03 |
| CAGR-FCPS | 0.00 | 0.00 | -0.01 | 0.01 | -0.01 | -0.02 | -0.11 | -0.01 | -0.06 | -0.02 | -0.07 | -0.03 |
| CAGR-BVPS | 0.00 | 0.00 | 0.01 | 0.07 | 0.08 | 0.41 | 0.24 | 0.22 | 0.19 | 0.14 | 0.04 | 0.03 |